| scholarly article | Q13442814 |
| P2093 | author name string | Wang W | |
| Castro O | |||
| Dosik H | |||
| Kinney TR | |||
| Rosse WF | |||
| Levy PS | |||
| Gallagher D | |||
| Moohr J | |||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1431-1437 | |
| P577 | publication date | 1990-10-01 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease | |
| P478 | volume | 76 |
| Q36068943 | 2015 proceedings of the National Heart, Lung, and Blood Institute's State of the Science in Transfusion Medicine symposium. |
| Q34792068 | A Genome-Wide Screen for Large-Effect Alloimmunization Susceptibility Loci among Red Blood Cell Transfusion Recipients with Sickle Cell Disease |
| Q60300292 | A locus on chromosome 5 shows African ancestry-limited association with alloimmunization in sickle cell disease |
| Q34960188 | Alloimmunization against RBC or PLT antigens is independent of TRIM21 expression in a murine model |
| Q34073152 | Alloimmunization and autoimmunization in transfusion dependent thalassemia major patients: Study on 319 patients |
| Q41948001 | Alloimmunization in Patients with Sickle Cell Disease and Thalassemia: Experience of a Single Centre in Oman. |
| Q47149254 | Alloimmunization in Thalassemia Patients: New Insight for Healthcare |
| Q37193725 | Alloimmunization in multitransfused liver disease patients: Impact of underlying disease |
| Q35672198 | Alloimmunization in sickle cell disease: changing antibody specificities and association with chronic pain and decreased survival |
| Q37254929 | Alloimmunization is associated with older age of transfused red blood cells in sickle cell disease |
| Q39166162 | Alloimmunization to transfused HOD red blood cells is not increased in mice with sickle cell disease. |
| Q92965152 | American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support |
| Q41982475 | An Attempt to Induce Transient Immunosuppression Pre-erythrocytapheresis in a Girl With Sickle Cell Disease, a History of Severe Delayed Hemolytic Transfusion Reactions and Need for Hip Prosthesis |
| Q48176949 | Antigen Density Dictates Immune Responsiveness following Red Blood Cell Transfusion. |
| Q35119955 | Approach to a case of multiple irregular red cell antibodies in a liver transplant recipient: Need for developing competence. |
| Q35949830 | Are microparticles the missing link between thrombosis and autoimmune diseases? Involvement in selected rheumatologic diseases. |
| Q52723453 | Association of IL-6 C-572G Gene Polymorphism with Anti-E Production. |
| Q36860550 | Barriers to hematopoietic cell transplantation clinical trial participation of african american and black youth with sickle cell disease and their parents |
| Q55427971 | Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management. |
| Q73422384 | Blood group genotyping in a population of highly diverse ancestry |
| Q36345020 | Clinical Factors Associated with Morbidity and Mortality in Patients Admitted with Sickle Cell Disease |
| Q34073155 | Clinical significance of antibody specificities to M, N and Lewis blood group system |
| Q61446927 | Coatings on mammalian cells: interfacing cells with their environment |
| Q64244900 | Comparative study of alloimmunization against red cell antigens in sickle cell disease & thalassaemia major patients on regular red cell transfusion |
| Q55252352 | Complement Component 3 Negatively Regulates Antibody Response by Modulation of Red Blood Cell Antigen. |
| Q93079966 | Complement serves as a switch between CD4+ T cell-independent and -dependent RBC antibody responses |
| Q33429704 | Crises in Sickle Cell Disease. |
| Q37040238 | Current management of sickle cell anemia |
| Q34679079 | DNA-based methods in the immunohematology reference laboratory |
| Q33724538 | Delayed hemolytic transfusion reaction in sickle cell disease |
| Q37133692 | Detection of alloimmunization to ensure safer transfusion practice |
| Q39943303 | Development of warm auto- and allo-antibodies in a 3-year old boy with sickle cell haemoglobinopathy following his first transfusion of a single unit of red blood cells |
| Q34170303 | Drug-loaded sickle cells programmed ex vivo for delayed hemolysis target hypoxic tumor microvessels and augment tumor drug delivery. |
| Q34067039 | Economic evaluation of a hypothetical screening assay for alloimmunization risk among transfused patients with sickle cell disease |
| Q52431898 | Enhancement of red blood cell transfusion compatibility using CRISPR-mediated erythroblast gene editing. |
| Q28389772 | Extensive genomic variability of knops blood group polymorphisms is associated with sickle cell disease in Africa |
| Q34792041 | Factors Influencing RBC Alloimmunization: Lessons Learned from Murine Models. |
| Q37048346 | Fatal Delayed Haemolytic Transfusion Reaction and Hyperhaemolysis Syndrome in a Pregnant Woman with Sickle Cell Anaemia |
| Q55492649 | Frequency of Red Blood Cell Alloimmunization in Patients with Sickle Cell Disease in Palestine. |
| Q36074678 | Frequency of Red Cell Alloimmunization and Autoimmunization in Thalassemia Patients: A Report from Eastern India |
| Q33969555 | Frequency of alloantibodies among chronic renal failure patients in red sea state |
| Q34792059 | Genetics of transfusion recipient alloimmunization: can clues from susceptibility to autoimmunity pave the way? |
| Q46702086 | Genomewide association study of HLA alloimmunization in previously pregnant blood donors |
| Q38274584 | Genomic analyses of RH alleles to improve transfusion therapy in patients with sickle cell disease |
| Q39149426 | Genotyping Applications for Transplantation and Transfusion Management: The Emory Experience |
| Q37231020 | Glucose-6-phosphate dehydrogenase deficiency in transfusion medicine: the unknown risks |
| Q37044218 | HLA alloimmunization is associated with RBC antibodies in multiply transfused patients with sickle cell disease |
| Q90332496 | Hb S/β-Thalassemia in the REDS-III Brazil Sickle Cell Disease Cohort: Clinical, Laboratory and Molecular Characteristics |
| Q33797355 | Hemin controls T cell polarization in sickle cell alloimmunization |
| Q57443498 | Hemoglobin A clearance in children with sickle cell anemia on chronic transfusion therapy |
| Q92420295 | Highly efficient editing of the β-globin gene in patient-derived hematopoietic stem and progenitor cells to treat sickle cell disease |
| Q53686375 | How I safely transfuse patients with sickle cell disease and manage delayed hemolytic transfusion reactions. |
| Q38928447 | Immune Regulation of sickle Cell Alloimmunization |
| Q34459335 | Immunologic characterization suggests reduced alloimmunization in a murine model of thalassemia intermedia |
| Q33667429 | Immunoregulatory networks in sickle cell alloimmunization |
| Q35145919 | Interethnic diversity of the CD209 (rs4804803) gene promoter polymorphism in African but not American sickle cell disease |
| Q37303143 | Leukoreduction and ultraviolet treatment reduce both the magnitude and the duration of the HLA antibody response |
| Q59798202 | Marginal Zone B Cells Induce Alloantibody Formation Following RBC Transfusion |
| Q36753265 | Molecular matching of red blood cells is superior to serological matching in sickle cell disease patients |
| Q48286678 | Motivation for blood donation among African Americans: developing measures for stage of change, decisional balance, and self-efficacy constructs |
| Q36830328 | Outcome and challenges of kidney transplant in patients with sickle cell disease |
| Q43224150 | Pattern and prevelence of alloimmunization in multiply transfused patients with sickle cell disease in Nigeria |
| Q26825713 | Pluripotent stem cells in research and treatment of hemoglobinopathies |
| Q36563588 | Protective effect of HLA-DQB1 alleles against alloimmunization in patients with sickle cell disease |
| Q35219015 | Rapid clearance of transfused murine red blood cells is associated with recipient cytokine storm and enhanced alloimmunogenicity. |
| Q90264974 | Red Blood Cell Alloimmunization in Multitransfused Pediatric Population in a Tertiary Care Hospital |
| Q42287014 | Red Blood Cell Alloimmunization in Sickle Cell Disease Patients in Tanzania |
| Q52640370 | Red blood cell alloimmunization in sickle cell disease: assessment of transfusion protocols during two time periods. |
| Q34792016 | Red blood cell alloimmunization in sickle cell disease: listen to your ancestors. |
| Q36106307 | Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management |
| Q37394897 | Red blood cell alloimmunization in sickle cell disease: prevalence in 2010. |
| Q42057952 | Red blood cell microparticles and blood group antigens: an analysis by flow cytometry |
| Q38637406 | Red blood cell minor antigen mismatches during chronic transfusion therapy for sickle cell anemia. |
| Q36277781 | Red blood cell storage duration is not associated with clinical outcomes for acute chest syndrome in children with sickle cell disease |
| Q42015408 | Red cell allo- and autoimmunisation in transfused sickle cell and cancer patients in Kenyatta National Hospital, Nairobi, Kenya |
| Q47095492 | Red cell alloimmunization is associated with development of autoantibodies and increased red cell transfusion requirements in myelodysplastic syndrome. |
| Q26471968 | Regular long-term red blood cell transfusions for managing chronic chest complications in sickle cell disease |
| Q37195103 | Regulatory B-cell compartment in transfused alloimmunized and non-alloimmunized patients with sickle cell disease |
| Q52575393 | Risk factors for red blood cell alloimmunization in the Recipient Epidemiology and Donor Evaluation Study (REDS-III) database. |
| Q35723452 | Sickle cell disease: old discoveries, new concepts, and future promise |
| Q30481765 | Sickle cell disease: ratio of blood flow velocity of intracranial to extracranial cerebral arteries--initial experience |
| Q36036759 | Sickle cell diseases: current therapeutic options and potential pitfalls in preventive therapy for transcranial Doppler abnormalities |
| Q35953361 | Stroke With Transfusions Changing to Hydroxyurea (SWiTCH). |
| Q34298893 | Stroke in children with sickle cell anaemia: aetiology and treatment |
| Q37528619 | Study of possible clinical and laboratory predictors of alloimmunization against red blood cell antigens in cancer patients |
| Q27000807 | The Influence of Clinical and Biological Factors on Transfusion-Associated Non-ABO Antigen Alloimmunization: Responders, Hyper-Responders, and Non-Responders |
| Q36907787 | The association of CD81 polymorphisms with alloimmunization in sickle cell disease |
| Q34231829 | The hazards of blood transfusion in historical perspective |
| Q37062530 | The persistence of red cell alloantibodies |
| Q35541746 | Transfusion complications in thalassemia patients: a report from the Centers for Disease Control and Prevention (CME). |
| Q55073506 | Transfusion in Haemoglobinopathies: Review and recommendations for local blood banks and transfusion services in Oman. |
| Q35776447 | Transfusion in the absence of inflammation induces antigen-specific tolerance to murine RBCs. |
| Q26851995 | Transfusion medicine problems and solutions for the pediatric hematologist/oncologist |
| Q35219113 | Transfusion of fresh murine red blood cells reverses adverse effects of older stored red blood cells |
| Q34718108 | Venous thromboembolism incidence in the Cooperative Study of Sickle Cell Disease. |
Search more.